Login
Astrazeneca PLC (ADR) NASDAQ: AZN
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company.
| Name | Astrazeneca PLC (ADR) |
| Ticker | AZN |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
|
Price
52W Low/High |
48.38
37.79 / 61.10 |
| Momentum | Neutral |
| Market cap | 127 B |
| 1Y Total Return |
11.48%
Below Average |
| 1Y Volatility |
35.98%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company.
Details
| Ticker | AZN |
| Name | Astrazeneca PLC (ADR) |
| ISIN | |
| CUSIP | 046353108 |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | Great Britain |
| Currency | U.S. Dollar |
Share as of 2/26/21
| Close Price | 48.38 |
| 52W Low/High | 37.79 / 61.10 |
| Market cap | 127 B |
| 1Y Total Return |
11.48%
Below Average |
| 1Y Volatility |
35.98%
Low Risk |
| Beta | 0.78 |
| PE (trailing) |
39.66
Above Average |
| 12M Dividends | 1.4 |
| Last Dividend Date | 8/13/20 |
| Dividend Yield | 2.89% |
Fin. Strength
| Net Profit Margin | 11.8% |
| Cash from Op. / Cur. Liabilities | 0.24 |
| Diluted Earnings / Share | 1.22 |
| ROE | 21.9% |
| ROIC | 6.8% |
| Price / Revenue | 2.4 |
| Price / Book | 4.1 |
| Price / CF | 13.2 |
| Current Ratio | 1.0 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.30 |
| in Mils USD |
rolling-year up to December
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
26,617
|
24,384
|
22,090
|
22,465
|
23,002
|
24,708
|
|
| Gross Profit |
21,318
|
19,463
|
17,154
|
18,147
|
18,876
|
20,062
|
|
| R&D |
5,991
|
6,059
|
5,932
|
5,757
|
5,890
|
5,997
|
|
| EBITDA |
8,371
|
6,742
|
7,165
|
6,771
|
7,293
|
6,996
|
|
| Operating Income |
5,162
|
2,924
|
3,387
|
3,677
|
4,902
|
4,114
|
|
| Net Income exc. Extra |
3,144
|
1,227
|
2,050
|
2,868
|
3,406
|
2,826
|
|
| per Share | |||||||
| Diluted avg Shares |
1,313
|
1,301
|
1,267
|
1,267
|
1,266
|
1,265
|
|
| EPS exc. Extra |
1.22
|
0.52
|
0.85
|
1.19
|
1.38
|
1.12
|
|
| Dividend |
1.40
|
1.40
|
1.40
|
1.40
|
1.40
|
2.35
|
|
| Div. Yield (an.) |
2.80%
|
2.81%
|
3.69%
|
4.03%
|
5.12%
|
6.92%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
66,729
|
61,377
|
60,651
|
63,354
|
62,526
|
60,056
|
|
| Cash, Eq & Invt ShortTerm |
7,992
|
6,218
|
5,680
|
4,554
|
5,902
|
6,853
|
|
| Total Current Assets |
19,544
|
15,563
|
15,591
|
13,150
|
13,262
|
16,007
|
|
| Total Non-Current Assets |
47,185
|
45,814
|
45,060
|
50,204
|
49,264
|
44,049
|
|
| Intangibles |
32,792
|
32,501
|
33,666
|
38,013
|
39,244
|
34,446
|
|
| Total Liabilities |
51,091
|
46,781
|
46,607
|
46,712
|
45,857
|
41,547
|
|
| Total Current Liabilities |
20,307
|
18,117
|
16,292
|
16,383
|
15,256
|
14,869
|
|
| Long Term Debt |
30,784
|
28,664
|
30,315
|
30,329
|
30,601
|
26,678
|
|
| Shareholder equity |
15,622
|
13,127
|
12,468
|
14,960
|
14,854
|
18,490
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
4,799
|
2,969
|
2,618
|
3,578
|
4,145
|
3,324
|
|
| Depreciation |
3,149
|
3,762
|
3,753
|
3,036
|
2,357
|
2,852
|
|
| Cash from Investing |
-285
|
-657
|
963
|
-2,328
|
-3,969
|
-4,239
|
|
| Capex |
855
|
942
|
1,031
|
1,243
|
1,364
|
1,281
|
|
| Cash from Financing |
-2,203
|
-1,765
|
-2,044
|
-2,936
|
-1,324
|
878
|
|
| Stock Issued |
30
|
3,525
|
34
|
43
|
47
|
43
|
|
| Debt (LT) Issued |
1,440
|
-1,702
|
1,473
|
560
|
2,172
|
4,372
|
|
| Free Cash Flow |
4,583
|
5,971
|
6,117
|
6,353
|
8,286
|
3,446
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
11.8%
|
5.0%
|
9.3%
|
12.8%
|
14.8%
|
11.4%
|
|
| NCFO / Op.Income |
93.0%
|
101.5%
|
77.3%
|
97.3%
|
84.6%
|
80.8%
|
|
| Current Ratio |
1.0
|
0.9
|
1.0
|
0.8
|
0.9
|
1.1
|
|
| Financial Leverage D/E |
1.30
|
1.39
|
1.53
|
1.19
|
1.13
|
0.81
|
|
| Return on Capital Avg |
6.8%
|
6.5%
|
8.4%
|
10.3%
|
11.6%
|
9.0%
|
|
| Return on Shareholder Equity |
21.9%
|
9.6%
|
14.9%
|
19.2%
|
20.4%
|
14.8%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available